Your browser doesn't support javascript.
loading
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.
Loap, Pierre; Loirat, Delphine; Berger, Frederique; Cao, Kim; Ricci, Francesco; Jochem, Anne; Raizonville, Laurence; Mosseri, Veronique; Fourquet, Alain; Kirova, Youlia.
Affiliation
  • Loap P; Department of Radiation Oncology, Institut Curie, Paris, France.
  • Loirat D; Department of Medical Oncology, Institut Curie, Paris, France.
  • Berger F; Department of Biostatistics, Institut Curie, Paris, France.
  • Cao K; Department of Radiation Oncology, Institut Curie, Paris, France.
  • Ricci F; Department of Clinical Investigations, Institut Curie, Paris, France.
  • Jochem A; Department of Biostatistics, Institut Curie, Paris, France.
  • Raizonville L; Department of Biostatistics, Institut Curie, Paris, France.
  • Mosseri V; Department of Biostatistics, Institut Curie, Paris, France.
  • Fourquet A; Department of Radiation Oncology, Institut Curie, Paris, France.
  • Kirova Y; Department of Radiation Oncology, Institut Curie, Paris, France.
Int J Cancer ; 149(10): 1828-1832, 2021 11 15.
Article in En | MEDLINE | ID: mdl-34270809
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Radiotherapy / Triple Negative Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Radiotherapy / Triple Negative Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2021 Type: Article Affiliation country: France